Tether, Tron Financial Crime Action Reaches Global Scale
A bold alliance between Tether, Tron, and TRM Labs is expanding enforcement beyond borders. With 23 countries in its ...
When To Rebalance Index Fund Retirement
This article explains practical timing for rebalancing index funds in retirement, helping you maintain targets and smooth withdrawals.
15,813 articles
Opinion: This Time It’s Different for the U.S. Loans Market
As Congress debates a sweeping housing bill, lenders and manufacturers warn about misaligned incentives. This opinion...
Microsoft Palantir: Plays, Winner in the AI Rally Today
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Best Time to Buy BTC Emerges: CoinGecko Signals US Holidays
A new CoinGecko analysis finds Bitcoin prices tend to post larger one-day gains when purchased on US holidays versus ...
China Will Remain ‘Incomplete’: U.S. Leads in Finance
A new financial snapshot shows the United States still leads in global finance even as diplomatic ties evolve. The yu...
Japan Bitcoin Plan Ready to Open Route for Household Savings
SBI Global Asset Management intends to launch Bitcoin and Ethereum ETFs and multi-asset crypto trusts after Japan ref...
Ecarx (ECX) 2026 Earnings Outlook: Q1 Review and Risks
Investors watching ecarx (ecx) 2026 earnings want clarity on how software, hardware, and services come together in th...
Meet Brothers Turned Homegrown AI Bet Transforms Work
In this story, meet brothers turned homegrown founders who built an in-house AI agent, then closed a $12 million seed...
Target's Turnaround Finally Here: What It Means for Investors
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
Lantern Pharma (LTRN) 2025 Investment Outlook and Updates
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Inside Fraud-Ripe Feeding Frenzy on Anthropic Shares
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status